Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
NCT ID | NCT04400474 |
Title | Trial of Cabozantinib Plus Atezolizumab in Advanced and Progressive Neoplasms of the Endocrine System. The CABATEN Study (CABATEN) |
Recruitment | Recruiting |
Gender | both |
Phase | Phase II |
Variant Requirements | No |
Sponsors | Grupo Espanol de Tumores Neuroendocrinos |
Indications |
gastrointestinal neuroendocrine tumor pulmonary neuroendocrine tumor |
Therapies | |
Age Groups: | senior | adult |
Covered Countries | ESP |